[Conference on the treatment of prostatic cancer. Munich, Germany, 2-3 November 1996].
Lansiaux
P
P
Service d'Urologie, Hôpital Léopold Bellan, Paris, France.
D000726:Androgen Antagonists / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005485:Flutamide / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D048289:Imidazolidines; D008197:Lymph Node Excision; D008297:Male; D016133:Polymerase Chain Reaction; D011467:Prostate / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D051381:Rats
D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D007093:Imidazoles; D048289:Imidazolidines; C021277:nilutamide; D005485:Flutamide; D017430:Prostate-Specific Antigen
Conférence sur le traitement du cancer de la prostate. Munich, Allemagne. 2-3 novembre 1996.